Fact CheckerSign in

NCT06929728Not yet recruiting

Automatic and Conventional Methods of Hypertensive Patients Monitoring

Copmaring Automatic Blood Preesure Measurments To Conventional Office Readings For Monitoring Hypertensive Patients And Predicting Hypertention Mediated Organ Damage

Source: ClinicalTrials.gov · Last updated 16 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

comparing automatic blood pressure measurments methods with conventional office methods in follow up and monitoring of hypertensive patients and predicting hypertension mediated organ damage .

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
620 (estimated)
First submitted
25 Mar 2025
Start date
Oct 2025
Primary completion date
Oct 2026
Lead sponsor
Assiut University
NCT number
NCT06929728

What you commit to

  • Study type: Observational
  • Planned participants: 620
  • From Oct 2025 to the primary completion date, Oct 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • patients with other cardiac diseases \[heart faliure ,valvular heart diseases \]
  • chronic illness affect blood pressure as chronic kideny disease .

Other

  • patients with secondary causes of hypertention

Who the study is looking for

  • Patients who were screening for suspected hypertention or white coat hypertention .
  • medically underserved population .
  • primary arterial hypertention .
  • high risk hypertensive patients \[resistant hypertension ,patients with poor medication adherance \]

Age in the registry: 18 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.